References
- Balakireva, O. M., Varban, M. Y., Yaremenko, A. A., Andrushchak, L., & Artukh, O. (2003). Perspectives for development of HIV prevention programmes among injection drug users. Kyiv: UNICEF.
- McCaffrey, B. R (1996, March). Treatment protocol effectiveness study. Executive Office of the President, Office of National Drug Control Policy. Washington, DC: ONDCP. Retrieved October 10, 1999, from http://www.ncjrs.orgiondcppubs/publications/treatitrmtprot.html.
- McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients. Journal of Nervous & Mental Diseases, 168, 26–33.
- McLellan, A. T., Luborsky, L., Cacciola, M. A., Griffith, J., Evans, F., Barr, H. L., et al. (1985). New data from the Addiction Severity Index: Reliability and validity in three centers. Journal of Nervous & Mental Diseases, 173, 412–423.
- McLellan, A. T., Alterman, A. I., Cacciola, J., Metzger, D., & O'Brien, C. P. (1992). A new measure of substance abuse treatment: initial studies of the treatment services review. Journal of Nervous & Mental Diseases, 180, 101–110.
- Metzger, D. S., Woody, G. E., McLellan, A. T., Druley, P., DePhilippis, D., O'Brien, C. P., et al. (1993). HIV conversion among in and out-of-treatment intravenous drug users in Philadelphia. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 6, 1049–1056.
- Navaline, H. A., Snider, E. C., Petro, C. J., Tobin, D., Metzger, D., Alterman, A. I., et al. (1994). Preparations for AIDS vaccine trials: An automated version of the Risk Assessment Battery (RAB): Enhancing the assessment of risk behaviors. AIDS Research and Human Retroviruses, 10, S281–283.